부산대학교 도서관

Spearman P; Tomaras G; Montefiori D; Huang Y; Ahmed H; Elizaga M; Hural J; McElrath J; Ouedraogo L; Pensiero M; Butler C; Kalams S; Overton ET; Barnett S; Group N

Retrovirology, Vol 9, Iss Suppl 2, p P137 (2012)

Goepfert P; Elizaga M; Montefiori D; Hural J; DeRosa S; Tomaras G; Seaton K; Sato A; Ouedraogo L; Donastorg Y; Cardinali M; Lama J; Baden L; Keefer M; McElrath J; Kalams S; Robinson H

Retrovirology, Vol 9, Iss Suppl 2, p O56 (2012)

Altfeld M; Kalams S; Sather D; Mikell I; Stamatatos L

Retrovirology, Vol 6, Iss Suppl 3, p P43 (2009)

Zhang B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Fong Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Fintzi J; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Chu E; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Janes HE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Kenny A; Department of Biostatistics, University of Washington, Seattle, WA, USA.; Carone M; Department of Biostatistics, University of Washington, Seattle, WA, USA.; Benkeser D; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.; van der Laan LWP; Department of Statistics, University of Washington, Seattle, WA, USA.; Deng W; Moderna, Inc, Cambridge, MA, USA.; Zhou H; Moderna, Inc, Cambridge, MA, USA.; Wang X; Moderna, Inc, Cambridge, MA, USA.; Lu Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Borate B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Chen H; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Reeder I; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Houchens CR; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Martins K; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Jayashankar L; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Huynh C; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Fichtenbaum CJ; Division of Infectious Diseases, Department of Medicine, University of Cincinnati, Cincinnati, OH, USA.; Kalams S; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.; Gay CL; Department of Medicine, Division of Infectious Diseases, UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Andrasik MP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.; Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.; Priddy F; Moderna, Inc, Cambridge, MA, USA.; Das R; Moderna, Inc, Cambridge, MA, USA.; Girard B; Moderna, Inc, Cambridge, MA, USA.; El Sahly HM; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.; Baden LR; Brigham and Women's Hospital, Boston, MA, USA.; Jones T; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Donis RO; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Koup RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Biostatistics, University of Washington, Seattle, WA, USA.; Follmann D; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. dfollmann@niaid.nih.gov.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Chirenje ZM; Department of Obstetrics and Gynecology, University of California San Francisco, San Francisco, California, USA.; Faculty of Medicine and Health Science, University of Zimbabwe Clinical Trials Research Centre, University of Zimbabwe, Harare, Zimbabwe.; Laher F; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Dintwe O; Cape Town HIV Vaccine Trials Network Immunology Laboratory, Cape Town, South Africa.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Muyoyeta M; Centre for Infectious Diseases Research in Zambia, Livingstone, Zambia.; deCamp AC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; He Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Grunenberg N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Laher Omar F; Cape Town HIV Vaccine Trials Network Immunology Laboratory, Cape Town, South Africa.; Seaton KE; Center for Human Systems Immunology, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.; Polakowski L; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.; Woodward Davis AS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Maganga L; National Institute for Medical Research-Mbeya Medical Research Centre, Mbeya, Tanzania.; Baden LR; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Mayer K; Beth Israel Deaconess Medical Center, Harvard University, Boston, Massachusetts, USA.; The Fenway Institute, Fenway Health, Boston, Massachusetts, USA.; Kalams S; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Keefer M; Department of Medicine, University of Rochester, Rochester, NewYork, USA.; Edupuganti S; Department of Medicine, Emory University, Atlanta, Georgia, USA.; Rodriguez B; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals, Cleveland Medical Center, Cleveland, Ohio, USA.; Frank I; School of Medicine, University of Pennsylvania, Philadelphia, USA.; Scott H; SanFrancisco Department of Public Health, San Francisco, California, USA.; Stranix-Chibanda L; Faculty of Medicine and Health Science, University of Zimbabwe Clinical Trials Research Centre, University of Zimbabwe, Harare, Zimbabwe.; Gurunathan S; Sanofi Pasteur, Swiftwater, Pennsylvania, USA.; Koutsoukos M; GSK, Wavre, Belgium.; Van Der Meeren O; GSK, Rixensart, Belgium.; DiazGranados CA; Sanofi Pasteur, Swiftwater, Pennsylvania, USA.; Paez C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Andersen-Nissen E; Cape Town HIV Vaccine Trials Network Immunology Laboratory, Cape Town, South Africa.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Kublin J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Ferrari G; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.; Tomaras G; Center for Human Systems Immunology, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.; McElrath MJ; Cape Town HIV Vaccine Trials Network Immunology Laboratory, Cape Town, South Africa.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

Al-Kaabi M; School of Human Sciences, University of Western Australia, Crawley, Australia.; Deshpande P; School of Human Sciences, University of Western Australia, Crawley, Australia.; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia.; Firth M; School of Physics, Mathematics and Computing, Department of Mathematics and Statistics, University of Western Australia, Crawley, Australia.; Pavlos R; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia.; Chopra A; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia.; Basiri H; School of Human Sciences, University of Western Australia, Crawley, Australia.; Currenti J; School of Human Sciences, University of Western Australia, Crawley, Australia.; Alves E; School of Human Sciences, University of Western Australia, Crawley, Australia.; Kalams S; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.; Fellay J; School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.; Swiss HIV Cohort Study, Zurich, Switzerland.; Phillips E; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia.; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.; Mallal S; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia.; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.; John M; School of Human Sciences, University of Western Australia, Crawley, Australia.; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia.; Department of Clinical Immunology, Royal Perth Hospital, Perth, Australia.; Gaudieri S; School of Human Sciences, University of Western Australia, Crawley, Australia.; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia.; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE

Miner MD; Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA. Electronic address: mminer@fredhutch.org.; deCamp A; Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA.; Grunenberg N; Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA.; De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine & Pathology, University of Washington, Seattle, WA, USA.; Fiore-Gartland A; Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA.; Bar K; University of Pennsylvania, Philadelphia, PA, USA.; Spearman P; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; Allen M; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Yu PC; Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA.; Manso B; Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA.; Frahm N; Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA.; Kalams S; Vanderbilt University Medical Center, Nashville, TN, USA.; Baden L; Brigham and Women's Hospital, Boston, MA, USA.; Keefer MC; Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, NY, USA.; Scott HM; San Francisco Department of Public Health, San Francisco, CA, USA.; Novak R; University of Illinois, Chicago, IL, USA.; Van Tieu H; Laboratory of Infectious Disease Prevention, Lindsley F. Kimball Research Institute, New York Blood Center, New York City, NY, USA; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York City, NY, USA.; Tomaras GD; Department of Surgery, Duke University, Durham, NC, USA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA.; McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA.; Corey L; Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, WA, USA.; Frank I; University of Pennsylvania, Philadelphia, PA, USA.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

Thomas LD; Department of Medicine, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.; Batarseh E; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Hamdan L; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Haddadin Z; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Dulek D; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Kalams S; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Stewart LS; 3Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Stahl AL; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Rahman H; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Amarin JZ; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Hayek H; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Ison M; Respiratory Disease Branch, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.; Overton ET; Department of Medicine, University Hospital, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Pergam SA; Department of Medicine, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Spieker AJ; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Halasa NB; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

Sobieszczyk ME; Columbia University Irving Medical Center, New York, NY, USA. Electronic address: mes52@cumc.columbia.edu.; Mannheimer S; Mailman School of Public Health, Columbia University, New York, NY, USA.; Paez CA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Gamble T; FHI 360, Durham, NC, USA.; Theodore DA; Columbia University Irving Medical Center, New York, NY, USA.; Chege W; National Institute of Allergy and Infectious Diseases, Rockville, MD, USA.; Yacovone M; National Institute of Allergy and Infectious Diseases, Rockville, MD, USA.; Hanscom B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Heptinstall J; Duke University School of Medicine, Durham, NC, USA.; Seaton KE; Duke University School of Medicine, Durham, NC, USA.; Zhang L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Miner MD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Eaton A; Duke University School of Medicine, Durham, NC, USA.; Weiner JA; Thayer School of Engineering, Dartmouth College, Hanover, NH, USA.; Mayer K; Fenway Institute, Boston, MA, USA.; Kalams S; Vanderbilt University Medical Center, Nashville, TN, USA.; Stephenson K; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.; Julg B; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.; Caskey M; Rockefeller University, New York, NY, USA.; Nussenzweig M; Rockefeller University, New York, NY, USA.; Gama L; Vaccine Research Center, National Institute of Health, Bethesda, MD, USA.; Barouch DH; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.; Ackerman ME; Thayer School of Engineering, Dartmouth College, Hanover, NH, USA.; Tomaras GD; Duke University School of Medicine, Durham, NC, USA.; Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Montefiori D; Duke University School of Medicine, Durham, NC, USA.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE

Wilson GJ; Vanderbilt University Medical Center, Nashville, TN, United States.; Rodriguez B; Case Western Reserve University, Cleveland, OH, United States.; Li SS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Allen M; DAIDS/NIAID/NIH, Rockville, MD, United States.; Frank I; University of Pennsylvania, Philadelphia, PA, United States.; Rudnicki E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Trahey M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Kalams S; Vanderbilt University Medical Center, Nashville, TN, United States.; Hannaman D; Ichor Medical Systems, San Diego, CA, United States.; Clarke DK; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States.; Xu R; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States.; Egan M; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States.; Eldridge J; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States.; Pensiero M; DAIDS/NIAID/NIH, Rockville, MD, United States.; Latham T; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States.; Ferrari G; Department of Surgery, Duke University, Durham, NC, United States.; Montefiori DC; Department of Surgery, Duke University, Durham, NC, United States.; Tomaras GD; Department of Surgery, Duke University, Durham, NC, United States.; De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Jacobson JM; Case Western Reserve University, Cleveland, OH, United States.; Miner MD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Elizaga M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.

Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE